MANGALAM DRUG & CHEM Stock Context for AI Screening

MANGALAM DRUG & CHEM LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for MANGALAM DRUG & CHEM, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive MANGALAM stock page

Price

₹28.24

1W return

-2.25%

1M return

-4.21%

3M return

+1.29%

6M return

+16.36%

1Y return

-65.70%

Market cap

₹44.70 cr

-1.01

0.43

ROE

-31.19%

ROCE

-13.30%

RSI

38.83

Turnover

₹0.06 cr

Why it can matter in screens

Momentum: MANGALAM is trend mixed or unavailable; RSI is 38.83.
Returns: 1D -0.18%, 1W -2.25%, 1M -4.21%, 3M +1.29%, 1Y -65.70%.
Trend levels: 52W high ₹92.46, 52W low ₹23.78, off high -69.46%.
Liquidity: latest turnover is ₹0.06 cr; volume vs 20D is +0.79%.
Valuation/profitability: PE -1.01, PB 0.43, ROE -31.19%, ROCE -13.30%.
Growth: 3Y sales CAGR -11.02%, 3Y profit CAGR -30.08%.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	67.29 cr	-5.53 cr	-13.42 cr	-8.48
2025-12-31	58.38 cr	-1.32 cr	-9.84 cr	-6.21
2025-09-30	49.26 cr	-2.81 cr	-7.35 cr	-4.64
2025-06-30	57.21 cr	-4.48 cr	-13.80 cr	-8.72
2025-03-31	72.78 cr	10.37 cr	0.06 cr	0.04
2024-12-31	88.55 cr	8.91 cr	n/a	nan
2024-09-30	79.75 cr	8.84 cr	n/a	1.70
2024-06-30	76.49 cr	8.23 cr	2.68 cr	1.70

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-03-31	315.19 cr	32.57 cr	6.72 cr	4.25
2024-03-31	365.49 cr	13.99 cr	-9.07 cr	-5.73
2023-03-31	365.97 cr	22.12 cr	1.27 cr	0.80
2022-03-31	447.37 cr	45.18 cr	19.66 cr	12.42
2021-03-31	n/a	n/a	n/a	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	314.97 cr	0.70 cr	105.48 cr	103.06 cr
2025-09-30	316.72 cr	3.38 cr	94.92 cr	127.57 cr
2025-03-31	366.42 cr	2.59 cr	96.23 cr	148.98 cr
2025-03-31	366.42 cr	2.59 cr	96.23 cr	148.98 cr
2024-09-30	364.11 cr	6.08 cr	83.00 cr	147.97 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	n/a	n/a	n/a
2025-12-31	n/a	n/a	n/a
2025-09-30	n/a	n/a	n/a
2025-06-30	n/a	n/a	n/a
2025-03-31	42.59 cr	22.39 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+35.65%	+0.32%	+0.00%	+0.00%	+64.02%	+0.00%
2025-12-31	+35.64%	+0.13%	+0.00%	+0.00%	+64.22%	+0.00%
2025-09-30	+50.30%	+0.11%	+0.00%	+0.00%	+49.58%	+0.00%
2025-06-30	+50.30%	+0.53%	+0.00%	+0.00%	+49.16%	+0.00%
2025-03-31	+50.30%	+0.47%	+0.00%	+0.00%	+49.23%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	429,121.06 cr	40.824543	+15.06%	+7.26%
DIVISLAB	DIVI S LABORATORIES LTD	174,585.42 cr	68.707369	+17.81%	+0.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	147,849.87 cr	68.354079	+29.94%	+39.35%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	119,204.71 cr	64.295958	+23.21%	+21.70%
CIPLA	CIPLA LTD	111,088.72 cr	29.624450	+12.91%	-6.65%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	108,331.15 cr	21.874917	+20.44%	+16.21%
DRREDDY	DR. REDDY S LABORATORIES	105,181.70 cr	24.542479	+13.88%	+1.20%
LUPIN	LUPIN LIMITED	103,385.66 cr	22.341869	+29.22%	+15.72%

Try these prompts

Analyze MANGALAM DRUG & CHEM with valuation, momentum and industry peers
Compare MANGALAM with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-06-03. Not investment advice.